REPORTS

Let’s Pullulate and Expand Your Business

Sterile Injectables Market - Global Professional Analysis and Forecast to 2026

Nov 04, 2019  |  184 PAGES  |  REPORT CODE: CMM228167
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Sterile Injectables market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.

This report presents the market size and development trends by detailing the Sterile Injectables market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Sterile Injectables market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Sterile Injectables industry and will help you to build a panoramic view of the industrial development.

Sterile Injectables Market, By Type:

  • Abilify Mantenna

  • Aristada

  • Zyprexa Relprevv

  • Invega Sustenna

  • Invega Trinza

  • Risperdal Consta

Sterile Injectables Market, By Application:

  • Intravenous

  • Intramuscular

  • Subcutaneous

Some of the leading players are as follows:

  • Amgen

  • Lilly

  • Alkermes

  • GlaxoSmithKline

  • Baxter International

  • F. Hoffmann

  • AstraZeneca

  • Otsuka America Pharmaceutical

  • Sanofi

  • AbbVie

  • Janssen Pharmaceuticals

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Sterile Injectables Market: Technology Type Analysis

  • 4.1 Sterile Injectables Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Sterile Injectables Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Abilify Mantenna

    • 4.3.2 Aristada

    • 4.3.3 Zyprexa Relprevv

    • 4.3.4 Invega Sustenna

    • 4.3.5 Invega Trinza

    • 4.3.6 Risperdal Consta

5 Sterile Injectables Market: Product Analysis

  • 5.1 Sterile Injectables Product Market Share Analysis, 2018 & 2026

  • 5.2 Sterile Injectables Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Sterile Injectables Market: Application Analysis

  • 6.1 Sterile Injectables Application Market Share Analysis, 2018 & 2026

  • 6.2 Sterile Injectables Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Intravenous

    • 6.3.2 Intramuscular

    • 6.3.3 Subcutaneous

7 Sterile Injectables Market: Regional Analysis

  • 7.1 Sterile Injectables Regional Market Share Analysis, 2018 & 2026

  • 7.2 Sterile Injectables Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Amgen

    • 9.1.1 Amgen Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Lilly

    • 9.2.1 Lilly Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Alkermes

    • 9.3.1 Alkermes Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 GlaxoSmithKline

    • 9.4.1 GlaxoSmithKline Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Baxter International

    • 9.5.1 Baxter International Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 F. Hoffmann

    • 9.6.1 F. Hoffmann Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 AstraZeneca

    • 9.7.1 AstraZeneca Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Otsuka America Pharmaceutical

    • 9.8.1 Otsuka America Pharmaceutical Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Sanofi

    • 9.9.1 Sanofi Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 AbbVie

    • 9.10.1 AbbVie Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Janssen Pharmaceuticals

    • 9.11.1 Janssen Pharmaceuticals Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 111 Figures and 149 Tables)

  • Figure Abilify Mantenna Sterile Injectables market, 2015 - 2026 (USD Million)

  • Figure Aristada Sterile Injectables market, 2015 - 2026 (USD Million)

  • Figure Zyprexa Relprevv Sterile Injectables market, 2015 - 2026 (USD Million)

  • Figure Invega Sustenna Sterile Injectables market, 2015 - 2026 (USD Million)

  • Figure Invega Trinza Sterile Injectables market, 2015 - 2026 (USD Million)

  • Figure Risperdal Consta Sterile Injectables market, 2015 - 2026 (USD Million)

  • Figure Intravenous market, 2015 - 2026 (USD Million)

  • Figure Intramuscular market, 2015 - 2026 (USD Million)

  • Figure Subcutaneous market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Sterile Injectables market, by country, 2015 - 2026 (USD Million)

  • Table North America Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table North America Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table North America Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Canada Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Canada Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Europe Sterile Injectables market, by country, 2015 - 2026 (USD Million)

  • Table Europe Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Europe Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Europe Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Germany Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Germany Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table France Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table France Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Italy Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Italy Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Spain Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Spain Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Sterile Injectables market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table China Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table China Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Japan Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Japan Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table India Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table India Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Sterile Injectables market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table MEA Sterile Injectables market, by country, 2015 - 2026 (USD Million)

  • Table MEA Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table MEA Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table MEA Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Sterile Injectables market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Sterile Injectables market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Sterile Injectables market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Amgen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alkermes Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Baxter International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Otsuka America Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top